Dermatology

National Alopecia Areata Foundation

4/1/12 → 3/31/17

Project: Research project

Intralesional cidofovir for the treatment of recalcitran

Polcari, I. C.

THE SOCIETY FOR PEDIATRIC DERMATOLOGY

10/22/15 → 4/21/17

Project: Research project

Epidermolysis Bullosa Clinical Characterization

EB RESEARCH PARTNERSHIP, INC.

8/5/15 → 6/30/17

Project: Research project

Keratinocytes control Langerhans cell migration by spati

Shaik, J.

Dermatology Foundation

7/1/14 → 6/30/17

Project: Research project

Cutaneous Findings in Fanconi Anemia and Patient Percept

Boull, C. L., Hook, K. P., Maguiness, S. & Polcari, I. C.

PEDIATRIC DERMATOLOGY RESEARCH ALLIANCE

7/1/16 → 12/31/17

Project: Research project

Characteristics of patients with mycosis fungoides/Sezar

Goyal-O'Leary, A.

AMERICAN SOCIETY OF HEMATOLOGY

7/1/17 → 6/30/18

Project: Research project

Epidermolysis Bullosa Clinical Characterization and Outc

Hook, K. P. & Boull, C. L.

EPIDERMOLYSIS BULLOSA MED RESEARCH FOUND

8/24/17 → 6/30/18

Project: Research project

A Randomized, Double-Blind, Double-Dummy

AMERICAN ACADEMY OF DERMATOLOGY

Genentech Inc.

12/17/14 → 12/16/18

Project: Research project

Program for Innovative Continuing Medical Education in D

Hurliman, E. & Reich, H. C.

1/1/17 → 12/31/18

Project: Research project

A 2-Year, Open-Label, Safety Extension Study of Gevokizu

Xoma Corporation

1/1/15 → 12/31/18

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled Study of

National Institutes of Health

Xoma Corporation

1/1/15 → 12/31/18

Project: Research project

Cannabinoid-based therapy and approaches to quantify pai

Gupta, K., Bagchi, A., Connett, J. E., Datta, Y. H., Ericson, M. E., He, B., Honda, C. N., Simone, D. A. & Ugurbil, K.

6/1/16 → 5/31/19

Project: Research project

Allogeneic skin grafting in the treatment of chronic

Shih, T. L. & Miller, D. D.

WOMEN'S DERMATOLOGIC SOCIETY

7/15/16 → 7/14/19

Project: Research project

An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)

CASTLE CREEK PHARMACEUTICALS, LLC

1/1/19 → 7/31/19

Project: Research project

A Multi-center Study to Evaluate the Pharmacokinetics ofDiacerein and Rhein and the Safety of Diacerein after MaximumUse, Topical Administration of CCP-020 (Diacerein 1%ointment) to Patients with Epidermolysis Bullosa (EB)

CASTLE CREEK PHARMACEUTICALS, LLC

1/21/19 → 7/31/19

Project: Research project

Cutaneous T-Cell Lymphoma study

Goyal-O'Leary, A.

AMERICAN SOCIETY OF HEMATOLOGY

7/1/18 → 9/30/19

Project: Research project

Intergrated Behavioral Healthcare in Dermatology: A C-Located Care Pilot Study.

Hordinsky, M. K. & Berge, J. M.

University of Wisconsin-Stout

10/1/18 → 9/30/19

Project: Research project

Severity and Culture Status in Epidermolysis Bullosa wit

PEDIATRIC DERMATOLOGY RESEARCH ALLIANCE

3/1/17 → 12/31/19

Project: Research project

MASTER A Research Study to Evaluate frontal fibrosing A

Jenkins, M. & Hordinsky, M. K.

Duke University

9/19/12 → 12/31/19

Project: Research project

Skin Dendritic Cells and Humoral Immunity

University of Pittsburgh

9/1/15 → 3/31/20

Project: Research project

APPLES: A prospective, pediatric, longitudinal evaluatio

Astellas Pharma US, Inc.

5/17/05 → 3/31/20

Project: Research project

A Phase 3, Multi-center, Randomized, Double-Blind

SCIODERM, INC.

4/20/16 → 4/30/20

Project: Research project

An Open Label Multi-Center Extension Study to Evaluate

SCIODERM, INC.

4/22/16 → 4/30/20

Project: Research project

A Prospective Observational Study of Treatment Patterns

Bohjanen, K. A. & Lee, P. K.

Genentech Inc.

6/3/13 → 6/30/20

Project: Research project

A PROSPECTIVE OBSERVATIONAL STUDY OF TREATMENT PATTERNS

Bohjanen, K. A. & Lee, P. K.

Genentech Inc.

6/3/13 → 6/30/20

Project: Research project

An Open-Label (Part A) and a Double-Blind, Randomized, P

Incyte Corporation

8/1/15 → 8/30/20

Project: Research project

A Randomized, Double-Blind Clinical Trial to Evaluate th

Lexington International, LLC

11/17/09 → 12/31/20

Project: Research project

The Impact of Pediatric Skin Disorders: The "Big" Study

Boull, C. L.

Northwestern University

9/13/19 → 12/31/20

Project: Research project

Phase IV Randomized Study of Two Dose Levels of Targetin

EISAI MEDICAL RESEARCH INC.

3/18/10 → 12/31/20

Project: Research project

Multicenter, Randomized, Double-Blind Placebo-Controlled

Allergan, Inc.

3/1/16 → 3/30/21

Project: Research project

An International, Multicenter, Randomized, Double-Blind,

MEDPACE, INC.

8/1/17 → 8/30/21

Project: Research project

A Randomized, Double-blind, Vehicle-controlled

ACLARIS THERAPEUTICS, INC

8/1/17 → 8/30/21

Project: Research project

WEN Shampoo Study

Farah, R. S. & Hordinsky, M. K.

CHAZ DEAN, INC.

8/27/18 → 10/31/21

Project: Research project

A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,

National University of Singapore

PFIZER, INC.

6/21/17 → 1/30/22

Project: Research project

Developing the next generation of safer 2-in-1 hair dye products

Bigliardi, P. L.

12/1/19 → 3/31/22

Project: Research project

Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficay of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma

SOLIGENIX INC

11/27/18 → 5/6/22

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis

ACLARIS THERAPEUTICS, INC

6/15/18 → 6/30/22

Project: Research project

An Open Label Extension Study to Assess the Long Term Safety and Efficacy of Dupilumab in Patients > 6months to < 18 years of age with Atopic Dermatitis

Maguiness, S.

Regeneron Pharmaceuticals, Inc.

11/1/17 → 11/30/22

Project: Research project

Measuring Alopecia Areata Patient-Reported Psychosocial Outcomes: Scale Development and Validation

Regeneron Pharmaceuticals, Inc.

PFIZER, INC.

10/7/20 → 1/31/23

Project: Research project

A Phase 2/3 Study Investigation the Phamacokinetics, Saf

Maguiness, S.

2/1/17 → 2/28/23

Project: Research project

Feasibility Study to Evaluate the Safety and Efficacy of Cellular Matrix??? BCT-HA Kit as a New Treatmentfor Dehydrated and Wrinkled Skin (A clinical and histological evaluation)

AMERICAN ACADEMY OF DERMATOLOGY

REGEN LAB SA

4/1/22 → 4/15/23

Project: Research project

Effect of mechanical intervention on the scalp microbiome: setting the stage for the future management of cicatricial alopecias

Farah, R. S., Staley, C. & Paiewonsky, B.

5/26/22 → 5/25/23

Project: Research project

Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors

Vogel, R. & Ahmed-Saucedo, R. L.

AMERICAN CANCER SOCIETY, INC.

7/1/19 → 6/30/23

Project: Research project

Mechanism of immune modulation by DPCP in alopecia

National Alopecia Areata Foundation

1/1/16 → 6/30/23

Project: Research project

Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-monthOpenlabelFollow-up of Oleogel-S10 in Patients with Inherited Epidermolysis Bullosa

AMRYT RESEARCH, LTD

8/30/18 → 8/30/23

Project: Research project

A Multicenter, Randomized, Double-Blind, PlaceboControlled, Operationally Seamless, Adaptive Phase 2/3Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very SevereAlopecia Areata

Eli Lilly G.m.b.H.

8/6/18 → 8/30/23

Project: Research project

A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study ofPatidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal CellCarcinomas (BCCs) in Subjects with Basal Cell Nevus

Maher, I.

PELLEPHARM, INC.

8/27/18 → 8/31/23

Project: Research project

A Phase 2B/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects with 50% or Greater Scalp Hair Loss

PFIZER, INC.

10/9/18 → 10/30/23

Project: Research project

Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), AlopeciaUniversalis (AU) and Alopecia Totalis (AT)